News about Global Pharma

Mirum Pharmaceuticals Announces the Appointment of Eric Bjerkholt as CFO

Bjerkholt brings extensive business leadership experience from roles served in the biopharmaceutical industry. He comes to Mirum from Chinook Therapeutics, Inc., where he served as CFO overseeing financial reporting, planning and budgeting, internal controls, investor relations, facilities, and information technology functions.

Global Pharma | 12/09/2023 | By Manvi |  731

Laurus Labs Limited Acquires Stake in Laurus Bio Private Limited

Pursuant to the above acquisition, the stake of the Company in Laurus Bio Private Limited shall reach to 87.58% on fully diluted basis (including outstanding ESOPs and the Share Warrants).

Global Pharma | 12/09/2023 | By Manvi |  1765

Norgine Appoints Saulo Martiniano as Chief Operating Officer

Saulo joins Norgine with a wealth of experience and a unique blend of leadership, operational expertise, and a deep understanding of manufacturing operational excellence and supply chain.

Global Pharma | 12/09/2023 | By Manvi |  440

Aurobindo Pharma's Telangana Plant Classified as VAI by US FDA

Pharmaceutical major Aurobindo Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (FDA) for its Unit III in the Bachupally Village, Telangana .

Global Pharma | 11/09/2023 | By Manvi |  1524

Strides Receives USFDA Approval for Sevelamer Carbonate for Oral Suspension

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Renvela for Oral Suspension, 0.8g and 2.4g of Genzyme.

Global Pharma | 11/09/2023 | By Manvi |  430

Natco Pharma, Others Sued in US for Generic Cancer Drug

Natco Pharma said the company and other drug makers have been named defendants in an antitrust lawsuit regarding a generic cancer treatment drug in the US.

Global Pharma | 11/09/2023 | By Manvi |  567

Strides Pharma Science Limited to Acquire 100% in Strides Pharma Services Pvt Ltd

Post the said acquisition, SPSPL shall be a direct WOS of the Company.

Global Pharma | 08/09/2023 | By Manvi |  1564

US FDA Inspects Aurobindo Pharma's Unit III in Telangana

The Unit has now received an Establishment Inspection Report classifying the facility as 'Voluntary Action Indicated' (VAI).

Global Pharma | 08/09/2023 | By Manvi |  815

IndiaRF to Acquire API and CRAMS Business of Ind-Swift Laboratories Limited Worth INR 1,650 Crores

Ind-Swift is amongst the top ten independent merchant API businesses in India in size, with two manufacturing sites in Punjab and Jammu, and a combined reactor capacity of ~700 KL catering to both regulated and unregulated markets.

Global Pharma | 08/09/2023 | By Manvi |  704

Schott Seeks More than USD 860 Million in Pharma Unit IPO

Schott Pharma announced plans for a stock sale, consisting of existing shares held by its parent, which will remain the majority shareholder.

Global Pharma | 07/09/2023 | By Manvi |  1189